Advanced Research in Pulmonary Pathophysiology

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".

Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 651

Special Issue Editors

E-Mail Website
Guest Editor
Department of Human Pathophysiology, Faculty of Nursing, University of Thessaly, 41500 Larissa, Greece
Interests: small airway disease; airway diseases; pleural pathophysiology; fibrotic diseases; microrna profiling

E-Mail Website
Guest Editor
Department of Nursing, University of Thessaly, 41500 Larissa, Greece
Interests: study of lung and pleural diseases through in silico, immunological, and molecular analyses

Special Issue Information

Dear Colleagues,

It is our pleasure to announce a Special Issue of Biomedicines, entitled “Advance Research in Pulmonary Pathophysiology”. To make meaningful progress in the field of lung-related illnesses, it is crucial to take a constructive approach towards advancing research in pulmonary pathophysiology. With lung pathology posing a significant threat to public health globally, we must work towards fostering a positive and collaborative research environment that encourages innovation and creativity. By investigating the pathophysiology of lung-related illnesses, we can obtain a deeper understanding of the underlying mechanisms that contribute to these diseases and develop more effective treatments. Through careful examination of the molecular, cellular, and physiological processes involved in lung diseases, it is possible to uncover new therapeutic targets and develop novel treatments that improve patient outcomes and quality of life.

This Biomedicines SI is dedicated to showcasing key areas of research in pulmonary pathophysiology. In particular, we aim to offer insights into the latest advancements of and innovative approaches in the spectrum of respiratory diseases, such as airway diseases, including the role of small airway disease in the development, progression and clinical outcomes of these conditions. Additionally, we aim to focus on allergy and its underlying neuroimmune pathways. Our goal is to delve into the role of microbiota in lung diseases, such as in occupational disorders, pulmonary fibrotic diseases, and molecular mechanisms influencing the pathogenesis of these entities. Moreover, we aim to present innovation-based research approaches in the field of lung cancer in order to revolutionize diagnosis and treatment, and among others recognize biomarkers regarding pleural pathophysiology, pulmonary infections, COVID-19, vascular respiratory diseases, sleep medicine, critical care, adult and pediatric medicine by presenting recent research on the changes that occur in normal mechanical, physical, and biochemical functions. Overall, this Special Issue has the goal of revealing new ideas by inspired collaborations and present recent advances in the area of respiratory pathophysiology.

Dr. Ourania S. Kotsiou
Dr. Erasmia Rouka
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • pathophysiology
  • aging
  • disease
  • injury
  • microbiome
  • small airways
  • pleura
  • lung cancer
  • infections
  • critical care

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop